- Home
- CRBU vs DTSQ Comparison
CRBU vs DTSQ Comparison
Compare CRBU & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- DTSQ
- Stock Information
- Founded
- CRBU 2011
- DTSQ 2022
- Country
- CRBU United States
- DTSQ United States
- Employees
- CRBU N/A
- DTSQ N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- DTSQ
- Sector
- CRBU Health Care
- DTSQ
- Exchange
- CRBU Nasdaq
- DTSQ NYSE
- Market Cap
- CRBU 93.0M
- DTSQ 91.7M
- IPO Year
- CRBU 2021
- DTSQ 2024
- Fundamental
- Price
- CRBU $1.63
- DTSQ $10.39
- Analyst Decision
- CRBU Strong Buy
- DTSQ
- Analyst Count
- CRBU 4
- DTSQ 0
- Target Price
- CRBU $8.50
- DTSQ N/A
- AVG Volume (30 Days)
- CRBU 1.9M
- DTSQ 531.0
- Earning Date
- CRBU 08-05-2025
- DTSQ 01-01-0001
- Dividend Yield
- CRBU N/A
- DTSQ N/A
- EPS Growth
- CRBU N/A
- DTSQ N/A
- EPS
- CRBU N/A
- DTSQ 0.28
- Revenue
- CRBU $9,918,000.00
- DTSQ N/A
- Revenue This Year
- CRBU $9.52
- DTSQ N/A
- Revenue Next Year
- CRBU N/A
- DTSQ N/A
- P/E Ratio
- CRBU N/A
- DTSQ $37.07
- Revenue Growth
- CRBU N/A
- DTSQ N/A
- 52 Week Low
- CRBU $0.66
- DTSQ $9.96
- 52 Week High
- CRBU $3.00
- DTSQ $10.49
- Technical
- Relative Strength Index (RSI)
- CRBU 66.57
- DTSQ N/A
- Support Level
- CRBU $1.34
- DTSQ N/A
- Resistance Level
- CRBU $1.79
- DTSQ N/A
- Average True Range (ATR)
- CRBU 0.12
- DTSQ 0.00
- MACD
- CRBU 0.03
- DTSQ 0.00
- Stochastic Oscillator
- CRBU 72.84
- DTSQ 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.